vs
百利高（PRGO）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
ROKU, INC的季度营收约是百利高的1.3倍（$1.4B vs $1.1B），ROKU, INC净利率更高（5.8% vs -127.8%，领先133.6%），ROKU, INC同比增速更快（16.1% vs -2.5%），百利高自由现金流更多（$148.6M vs $106.6M），过去两年ROKU, INC的营收复合增速更高（25.8% vs 1.3%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
PRGO vs ROKU — 直观对比
营收规模更大
ROKU
是对方的1.3倍
$1.1B
营收增速更快
ROKU
高出18.7%
-2.5%
净利率更高
ROKU
高出133.6%
-127.8%
自由现金流更多
PRGO
多$42.0M
$106.6M
两年增速更快
ROKU
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.4B |
| 净利润 | $-1.4B | $80.5M |
| 毛利率 | 32.6% | 43.5% |
| 营业利润率 | -116.0% | 4.7% |
| 净利率 | -127.8% | 5.8% |
| 营收同比 | -2.5% | 16.1% |
| 净利润同比 | -3093.9% | 326.4% |
| 每股收益（稀释后） | $-10.23 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGOROKU
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.0B | $1.0B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.1B | $968.2M | ||
| Q1 24 | $1.1B | $881.5M |
净利润PRGOROKU
| Q4 25 | $-1.4B | $80.5M | ||
| Q3 25 | $7.5M | $24.8M | ||
| Q2 25 | $-8.4M | $10.5M | ||
| Q1 25 | $-6.4M | $-27.4M | ||
| Q4 24 | $-44.4M | $-35.5M | ||
| Q3 24 | $-21.0M | $-9.0M | ||
| Q2 24 | $-108.4M | $-34.0M | ||
| Q1 24 | $2.0M | $-50.9M |
毛利率PRGOROKU
| Q4 25 | 32.6% | 43.5% | ||
| Q3 25 | 36.1% | 43.4% | ||
| Q2 25 | 34.4% | 44.8% | ||
| Q1 25 | 37.6% | 43.6% | ||
| Q4 24 | 33.9% | 42.7% | ||
| Q3 24 | 37.2% | 45.2% | ||
| Q2 24 | 37.0% | 43.9% | ||
| Q1 24 | 33.1% | 44.1% |
营业利润率PRGOROKU
| Q4 25 | -116.0% | 4.7% | ||
| Q3 25 | 7.0% | 0.8% | ||
| Q2 25 | 4.3% | -2.1% | ||
| Q1 25 | 4.5% | -5.7% | ||
| Q4 24 | 10.0% | -3.3% | ||
| Q3 24 | 7.4% | -3.4% | ||
| Q2 24 | -2.5% | -7.4% | ||
| Q1 24 | -5.1% | -8.2% |
净利率PRGOROKU
| Q4 25 | -127.8% | 5.8% | ||
| Q3 25 | 0.7% | 2.0% | ||
| Q2 25 | -0.8% | 0.9% | ||
| Q1 25 | -0.6% | -2.7% | ||
| Q4 24 | -3.9% | -3.0% | ||
| Q3 24 | -1.9% | -0.9% | ||
| Q2 24 | -10.2% | -3.5% | ||
| Q1 24 | 0.2% | -5.8% |
每股收益（稀释后）PRGOROKU
| Q4 25 | $-10.23 | $0.55 | ||
| Q3 25 | $0.05 | $0.16 | ||
| Q2 25 | $-0.06 | $0.07 | ||
| Q1 25 | $-0.05 | $-0.19 | ||
| Q4 24 | $-0.32 | $-0.24 | ||
| Q3 24 | $-0.15 | $-0.06 | ||
| Q2 24 | $-0.79 | $-0.24 | ||
| Q1 24 | $0.01 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.3B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.9B | $2.7B |
| 总资产 | $8.5B | $4.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRGOROKU
| Q4 25 | — | $2.3B | ||
| Q3 25 | $432.1M | $2.3B | ||
| Q2 25 | $454.2M | $2.3B | ||
| Q1 25 | $409.9M | $2.3B | ||
| Q4 24 | $558.8M | $2.2B | ||
| Q3 24 | $1.5B | $2.1B | ||
| Q2 24 | $542.8M | $2.1B | ||
| Q1 24 | $658.5M | $2.1B |
股东权益PRGOROKU
| Q4 25 | $2.9B | $2.7B | ||
| Q3 25 | $4.4B | $2.6B | ||
| Q2 25 | $4.5B | $2.6B | ||
| Q1 25 | $4.4B | $2.5B | ||
| Q4 24 | $4.3B | $2.5B | ||
| Q3 24 | $4.6B | $2.5B | ||
| Q2 24 | $4.5B | $2.4B | ||
| Q1 24 | $4.7B | $2.4B |
总资产PRGOROKU
| Q4 25 | $8.5B | $4.4B | ||
| Q3 25 | $10.1B | $4.4B | ||
| Q2 25 | $10.1B | $4.3B | ||
| Q1 25 | $9.8B | $4.2B | ||
| Q4 24 | $9.6B | $4.3B | ||
| Q3 24 | $11.2B | $4.3B | ||
| Q2 24 | $10.4B | $4.1B | ||
| Q1 24 | $10.6B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | $107.7M |
| 自由现金流经营现金流 - 资本支出 | $148.6M | $106.6M |
| 自由现金流率自由现金流/营收 | 13.4% | 7.6% |
| 资本支出强度资本支出/营收 | 2.4% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 1.34× |
| 过去12个月自由现金流最近4个季度 | $145.1M | $478.4M |
8季度趋势，按日历期对齐
经营现金流PRGOROKU
| Q4 25 | $175.4M | $107.7M | ||
| Q3 25 | $51.7M | $127.6M | ||
| Q2 25 | $75.9M | $109.7M | ||
| Q1 25 | $-64.5M | $138.7M | ||
| Q4 24 | $312.6M | $79.3M | ||
| Q3 24 | $42.2M | $68.7M | ||
| Q2 24 | $9.5M | $23.4M | ||
| Q1 24 | $-1.4M | $46.7M |
自由现金流PRGOROKU
| Q4 25 | $148.6M | $106.6M | ||
| Q3 25 | $29.8M | $126.5M | ||
| Q2 25 | $56.7M | $108.6M | ||
| Q1 25 | $-90.0M | $136.8M | ||
| Q4 24 | $274.9M | $76.8M | ||
| Q3 24 | $15.1M | $67.6M | ||
| Q2 24 | $-18.9M | $22.5M | ||
| Q1 24 | $-26.5M | $46.0M |
自由现金流率PRGOROKU
| Q4 25 | 13.4% | 7.6% | ||
| Q3 25 | 2.9% | 10.4% | ||
| Q2 25 | 5.4% | 9.8% | ||
| Q1 25 | -8.6% | 13.4% | ||
| Q4 24 | 24.2% | 6.4% | ||
| Q3 24 | 1.4% | 6.4% | ||
| Q2 24 | -1.8% | 2.3% | ||
| Q1 24 | -2.4% | 5.2% |
资本支出强度PRGOROKU
| Q4 25 | 2.4% | 0.1% | ||
| Q3 25 | 2.1% | 0.1% | ||
| Q2 25 | 1.8% | 0.1% | ||
| Q1 25 | 2.4% | 0.2% | ||
| Q4 24 | 3.3% | 0.2% | ||
| Q3 24 | 2.5% | 0.1% | ||
| Q2 24 | 2.7% | 0.1% | ||
| Q1 24 | 2.3% | 0.1% |
现金转化率PRGOROKU
| Q4 25 | — | 1.34× | ||
| Q3 25 | 6.89× | 5.14× | ||
| Q2 25 | — | 10.45× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
ROKU
| Services | $1.2B | 88% |
| Products | $170.9M | 12% |
